metformin has been researched along with Wolfram Syndrome in 1 studies
Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.
Wolfram Syndrome: A hereditary condition characterized by multiple symptoms including those of DIABETES INSIPIDUS; DIABETES MELLITUS; OPTIC ATROPHY; and DEAFNESS. This syndrome is also known as DIDMOAD (first letter of each word) and is usually associated with VASOPRESSIN deficiency. It is caused by mutations in gene WFS1 encoding wolframin, a 100-kDa transmembrane protein.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hofmann, M | 1 |
Boehmer, H | 1 |
Zumbach, M | 1 |
Borcea, V | 1 |
Grauer, A | 1 |
Kasperk, C | 1 |
Heilmann, P | 1 |
Ziegler, R | 1 |
Wahl, P | 1 |
Nawroth, PP | 1 |
1 review available for metformin and Wolfram Syndrome
Article | Year |
---|---|
[The Wolfram syndrome: diabetes mellitus, hypacusis, optic atrophy and short stature in STH deficiency].
Topics: Adult; Drug Therapy, Combination; Glyburide; Growth Disorders; Human Growth Hormone; Humans; Hypogly | 1997 |